Drug development times are painfully long, with patients waiting years upon years for new medicines to hit the market. Verisian is hoping to change this, with a range of tools to facilitate faster drug trialling and analysis of results.
The company's products target know pain-points in the clinical trial pipeline. For example, Verisian Builder allows trials to be designed faster by supplying a library of pre-approved modules based on existing studies. Trials can be pooled for analysis with Verisian Pooler, while data can be extracted and virtualised with Verisian Tracer.
Verisian is advancing its mission to streamline clinical trails with the release of its first product, Validator, which traces data lineage in SAS outputs to support automated study validation. Now, the team is focused on developing Builder, an AI-powered tool for designing and validating studies, while expanding partnerships with tier-1 pharmaceutical companies.
Kirsty
Company Specialist at Welcome to the Jungle